Format

Send to

Choose Destination
Neurodegener Dis. 2019 Dec 17:1-9. doi: 10.1159/000504302. [Epub ahead of print]

Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects.

Author information

1
CIRD Centre d'Imagerie Rive Droite, Geneva, Switzerland, sven.haller@gmail.com.
2
Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden, sven.haller@gmail.com.
3
Faculty of Medicine, University of Geneva, Geneva, Switzerland, sven.haller@gmail.com.
4
Department of Rehabilitation and Geriatrics, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
5
Department of Psychiatry, University of Geneva, Geneva, Switzerland.
6
Division of Institutional Measures, Medical Direction, Geneva University Hospitals, Geneva, Switzerland.
7
Faculty of Medicine, University of Geneva, Geneva, Switzerland.
8
Division of Nuclear Medicine and Molecular Imaging, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.

Abstract

BACKGROUND:

Hippocampal volume loss (HVL), PET-documented brain amyloid accumulation, and APOE-ε4 status are predictive biomarkers of the transition from mild cognitive impairment to Alzheimer disease (AD). In asymptomatic cases, the role of these biomarkers remains ambiguous. In contrast to the idea that HVL occurs in late phases of neurodegeneration, recent contributions indicate that it might occur before abnormal amyloid PET occurrence in elderly subjects and that its severity could be only marginally related to APOE variants. Using a longitudinal design, we examined the determinants of HVL in our sample, i.e., brain amyloid burden and the presence of APOE-ε4, and made a longitudinal assessment of cognitive functions.

METHODS:

We performed a 4.5-year longitudinal study on 81 elderly community dwellers (all right-handed;, 48 (59.3%) women; mean age 73.7 ± 3.7 years) including MRI at baseline and follow-up, PET amyloid during follow-up, neuropsychological assessment at 18 and 54 months, and APOE genotyping. All cases were assessed using a continuous cognitive score (CCS) that took into account the global evolution of neuropsychological performance. Linear regression models were used to identify predictors of HVL.

RESULTS:

There was a negative association between the CCS and HVL bilaterally. In multivariate models adjusting for demographic variables, the presence of APOE-ε4 was related to increased HVL bilaterally. A trend of significance was observed with respect to the impact of amyloid positivity on HVL in the left hemisphere. No significant interaction was found between amyloid positivity and the APOE-ε4 allele.

CONCLUSION:

The progressive decrement of neuropsychological performance is associated with HVL long before the emergence of clinically overt symptoms. In this cohort of healthy individuals, the presence of the APOE-ε4 allele was shown to be an independent predictor of worst hippocampal integrity in asymptomatic cases independently of amyloid positivity.

KEYWORDS:

APOE; Aging; Amyloid; Hippocampus

PMID:
31846965
DOI:
10.1159/000504302

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center